Viking Therapeutics (VKTX) Tops Q3 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy